Gogoro Inc vs Intuitive Surgical, Inc. — how do they compare? Gogoro Inc trades at $3.8 (market cap $77.38M), while Intuitive Surgical, Inc. trades at $381.99 (market cap $137.76B). The key difference: Intuitive Surgical, Inc. is far larger — about 1780.3× Gogoro Inc's market cap, and Gogoro Inc is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals.
| GGR | ISRG | |
|---|---|---|
Market Cap | $77.38M | $137.76B |
Sector | Technology | Health |
52-Week High | $7.89 | $592.85 |
52-Week Low | $2.74 | $379.50 |
Enterprise Value | $379.83M | $133.24B |
Signals from Pluang's Aura AI — not financial advice
Gogoro Inc. (GGR) trades at $3.86, up 1.58% on the day, but remains in a technically bearish trend. Fundamentally, the company reported Q1 2026 results highlighting improved margins and positive operating cash flow, though it continues to post significant net losses with a -24.68% net income margin. The analyst consensus is unanimously neutral with a 100% Hold rating, reflecting caution despite recent operational progress.
The outlook is mixed. Opportunities stem from Gogoro's growing battery-swapping subscriber base and expansion into new markets like Vietnam. However, significant risks persist, including sustained unprofitability, high cash burn with a net cash flow of -$46.57M in 2025, and negative shareholder returns evidenced by a -50.38% ROE. The stock's low P/S of 0.21 suggests the market has heavily discounted its growth prospects.
Intuitive Surgical (ISRG) trades at $399.75, up 5.34% today, but remains 25% below its 52-week high amid 2026 weakness. The stock shows bearish technical signals with key resistance near $402, while fundamentals remain strong with consistent revenue growth to $10.06B in 2025 and a 28.15% net margin. Recent quarters have seen earnings beats, with Q2 2026 results due July 16. Analyst sentiment is predominantly bullish with a $552.36 price target, though competition concerns persist.
Outlook: Long-term growth prospects in robotic surgery are compelling, supported by da Vinci 5 adoption and AI integration. Near-term risks include margin pressure and competitive threats. The stock offers potential upside if Q2 earnings beat expectations, but volatility may continue until growth catalysts materialize.
Trailing returns across standard periods
Latest headlines on both assets
Gogoro is a global technology leader in battery-swapping ecosystems for electric two-wheelers. It provides smart, sustainable urban mobility solutions and manages an extensive network of battery stations.
Read more on GGR →Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →